Human gene therapy - JoVE Visualize

Showing results (2511-2520 of 4,125) with videos related to

Pageof 413

Sort By:

Human Gene Therapy|September 9, 2022

Cellular and Structural Characterization of VP1 and VP2 Knockout Mutants of AAV3B Serotype and Implications for AAV ManufacturingIker Arriaga, Aitor Navarro, Amaia Etxabe, et al.

Human Gene Therapy|December 1, 1994

High-efficiency gene transfer to autologous rabbit jugular vein grafts using adenovirus-transferrin/polylysine-DNA complexesJ M Kupfer, X M Ruan, G Liu, et al.

Human Gene Therapy|December 1, 1994

Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cellsJ H Kim, S Ratto, K V Sitz, et al.

Human Gene Therapy|February 1, 1995

Suppression of single and double nonsense mutations introduced into the diphtheria toxin A-chain gene: a potential binary system for toxin gene therapyD F Robinson, I H Maxwell

Human Gene Therapy|February 1, 1995

Safety evaluation of Ad5CMV-p53 in vitro and in vivoW W Zhang, R Alemany, J Wang, et al.

Human Gene Therapy|January 1, 1995

Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transferF Moreau-Gaudry, C Ged, C Barbot, et al.

Human Gene Therapy|January 1, 1995

A phase I trial of B7-transfected or parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401R T Fenton, M Sznol, D G Luster, et al.

Human Gene Therapy|March 1, 1995

The effect of selection for high-level vector expression on the genetic and functional stability of a single transcript vector derived from a low-leukemogenic murine retrovirusM Duch, K Paludan, J Lovmand, et al.

Human Gene Therapy|March 1, 1995

Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vectorB J Roessler, J W Hartman, D K Vallance, et al.

Human Gene Therapy|March 1, 1995

Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapyI P Wicks, M L Howell, T Hancock, et al.

Pageof 413

Showing results (2511-2520 of 4,125) with videos related to

Sort By:

Pageof 413

Human Gene Therapy|September 9, 2022

Cellular and Structural Characterization of VP1 and VP2 Knockout Mutants of AAV3B Serotype and Implications for AAV ManufacturingIker Arriaga, Aitor Navarro, Amaia Etxabe, et al.

Human Gene Therapy|December 1, 1994

High-efficiency gene transfer to autologous rabbit jugular vein grafts using adenovirus-transferrin/polylysine-DNA complexesJ M Kupfer, X M Ruan, G Liu, et al.

Human Gene Therapy|December 1, 1994

Consequences of stable transduction and antigen-inducible expression of the human interleukin-7 gene on tetanus-toxoid-specific T cellsJ H Kim, S Ratto, K V Sitz, et al.

Human Gene Therapy|February 1, 1995

Suppression of single and double nonsense mutations introduced into the diphtheria toxin A-chain gene: a potential binary system for toxin gene therapyD F Robinson, I H Maxwell

Human Gene Therapy|February 1, 1995

Safety evaluation of Ad5CMV-p53 in vitro and in vivoW W Zhang, R Alemany, J Wang, et al.

Human Gene Therapy|January 1, 1995

Correction of the enzyme defect in cultured congenital erythropoietic porphyria disease cells by retrovirus-mediated gene transferF Moreau-Gaudry, C Ged, C Barbot, et al.

Human Gene Therapy|January 1, 1995

A phase I trial of B7-transfected or parental lethally irradiated allogeneic melanoma cell lines to induce cell-mediated immunity against tumor-associated antigen presented by HLA-A2 or HLA-A1 in patients with stage IV melanoma. NCI protocol T93-0161. BRMP protocol 9401R T Fenton, M Sznol, D G Luster, et al.

Human Gene Therapy|March 1, 1995

The effect of selection for high-level vector expression on the genetic and functional stability of a single transcript vector derived from a low-leukemogenic murine retrovirusM Duch, K Paludan, J Lovmand, et al.

Human Gene Therapy|March 1, 1995

Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vectorB J Roessler, J W Hartman, D K Vallance, et al.

Human Gene Therapy|March 1, 1995

Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapyI P Wicks, M L Howell, T Hancock, et al.

Pageof 413